Key result
Bariatric surgery is linked to ~15 mmHg lower systolic blood pressure at 10 years.
Why the study?
Current guidelines support bariatric surgery as an effective treatment mainly for severe obesity and poorly controlled hypertension, but evidence in non-severely obese Asian populations remained limited.
Does bariatric surgery (LSG or LRYGB) reduce short-, intermediate-, and long-term blood pressure and improve hypertension control in Chinese patients with obesity and hypertension?
Cohort (n=248)
Yes
Does bariatric surgery (LSG or LRYGB) reduce short-, intermediate-, and long-term blood pressure and improve hypertension control in Chinese patients with obesity and hypertension?
Bariatric surgery in Chinese patients with obesity and hypertension produces rapid blood pressure reductions within the first postoperative week that are sustained for up to 10 years across both severe and non-severe obesity phenotypes, appearing largely independent of the magnitude of weight loss.
Answers are grounded in this paper and cite their sources.
Bariatric surgery was associated with sustained BP reductions; extends low-certainty observational data but leaves open need for RCTs before practice change.
Current guidelines support bariatric surgery (BS) as an effective treatment mainly for patients with severe obesity and poorly controlled hypertension. However, evidence in non‐severely obese Asian populations remains limited. This multicenter prospective cohort study included 248 Chinese patients with obesity and hypertension who underwent BS between 2010 and 2019 and were followed for up to 10 years. An exploratory mechanistic substudy ( n = 14) evaluated 24‐h ambulatory blood pressure (BP), various biomarkers, and urinary electrolytes before and after BS. Compared with baseline, adjusted mean systolic blood pressure (SBP) was lower by 16.4, 14.8, 15.1, 18.0, and 15.2 mmHg, while diastolic blood pressure (DBP) decreased by 11.4, 9.1, 9.9, 10.5, and 11.4 mmHg at 3 months, 6 months, and 1, 5, 10 years postoperatively. During postoperative Days 1 to 7 (POD1‐7), mean SBP and DBP dropped by 8.6 and 10.4 mmHg, and the proportion achieving BP < 140/90 mmHg increased to 62.9% and remained at 70.8% even 10 years later. The substudy has observed that early BP reduction was accompanied by increased electrolytes and water excretion, as well as a transient suppression of renin‐angiotensin‐aldosterone system (RAAS)‐related biomarkers, providing a direction for future in‐depth exploration. These findings suggest that BS in Chinese patients was followed by rapid BP reductions, with lower BP observed among the smaller subsets assessed longer term, including those without severe obesity. Trial Registration : NCT07183137.
No takes yet. Share an insight, caveat, or question.
Zhong et al. (2026) conducted a cohort in Obesity and hypertension (n=248). Bariatric surgery (laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy) vs. Preoperative baseline (within-subject comparison) was evaluated on Adjusted mean change in systolic blood pressure (SBP) at 10 years postoperatively compared to baseline (MD -15.17 mmHg, 95% CI -19.85 to -10.49, p=<0.001). Bariatric surgery reduced adjusted mean systolic blood pressure by 15.17 mmHg (95% CI -19.85 to -10.49; p<0.001) and controlled BP (<140/90 mmHg) in 70.83% of patients at 10 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: